Pangaea Oncology, S.A. (PANG.MC)

EUR 1.7

(1.19%)

Revenue Summary of Pangaea Oncology, S.A.

  • Pangaea Oncology, S.A.'s latest annual revenue in 2023 was 7.99 Million EUR , up 83.12% from previous year.
  • Pangaea Oncology, S.A.'s latest quarterly revenue in 2023 FY was 7.99 Million EUR , up 83.12% from previous quarter.
  • Pangaea Oncology, S.A. reported a annual revenue of 4.36 Million EUR in annual revenue 2022, down -5.11% from previous year.
  • Pangaea Oncology, S.A. reported a annual revenue of 4.6 Million EUR in annual revenue 2021, up 12.29% from previous year.
  • Pangaea Oncology, S.A. reported a quarterly revenue of 1.73 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • Pangaea Oncology, S.A. reported a quarterly revenue of 3.23 Million EUR for 2023 Q3, up 86.2% from previous quarter.

Annual Revenue Chart of Pangaea Oncology, S.A. (2023 - 2013)

Created with Highcharts 11.1.0YearsRevenue201320142015201620172018201920202021202220230 EUR2000000 EUR4000000 EUR6000000 EUR8000000 EUR10000000 EUR

Historical Annual Revenue of Pangaea Oncology, S.A. (2023 - 2013)

Year Revenue Revenue Growth
2023 7.99 Million EUR 83.12%
2022 4.36 Million EUR -5.11%
2021 4.6 Million EUR 12.29%
2020 4.09 Million EUR 23.61%
2019 3.31 Million EUR 8.44%
2018 3.05 Million EUR 16.65%
2017 2.62 Million EUR 4.11%
2016 2.51 Million EUR 29.17%
2015 1.94 Million EUR 13.52%
2014 1.71 Million EUR -44.4%
2013 3.08 Million EUR 0.0%

Peer Revenue Comparison of Pangaea Oncology, S.A.

Name Revenue Revenue Difference
Clínica Baviera, S.A. 224.92 Million EUR 96.444%